Market share of Lianhua Qingwen in public healthcare in China H1 2022
In the first half of 2022, Yiling Pharmaceutical's Lianhua Qingwen had a market share of almost 36 percent in Chinese public healthcare. Due to the epidemic, there was a significant increase in market share in 2020.